← Open Payments lookup

MANDIE MILLER: Open Payments

NPI 1609152479 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,233 in 127 payments from 15 companies in 2025. Trend: 2023 $1,720 · 2024 $2,457 · 2025 $2,233

Food & beverage: $2,122Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$427
Lundbeck LLC11$243
Otsuka America Pharmaceutical, Inc.13$223
Vanda Pharmaceuticals Inc.9$191
Teva Pharmaceuticals USA, Inc.8$189
Axsome Therapeutics, Inc.11$185
Neurocrine BioSciences, Inc.14$183
ABBVIE INC.11$176
E.R. Squibb & Sons, L.L.C.10$139
Alkermes, Inc.6$100

Products named: REXULTI, CAPLYTA, Auvelity, INGREZZA, VRAYLAR, FANAPT, COBENFY, ARISTADA.

Industry payments across AZ — which companies pay providers there.